Bio-Techne Shareholders Approve Takeover by Merck KGaA

09:46 AM EDT, 09/23/2026 (MT Newswires) -- Bio-Techne (TECH) said its shareholders approved the proposed takeover by Germany's Merck KGaA at a special meeting held Wednesday. The company also said the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 expired on Sept. 18. In June, the company said it signed an agreement to be acquired by Merck KGaA for $73 a share, for an enterprise value of $11.3 billion. Bio-Techne said it continues to expect the transaction to close by late 2026 or early 2027. Price: 72.62, Change: +0.06, Percent Change: +0.09